PF-06649751 Uses, Dosage, Side Effects and more
PF-06649751 is under investigation in clinical trial NCT02262767 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects).
| Attribute | Details |
|---|---|
| Trade Name | PF-06649751 |
| Generic | Tavapadon |
| Tavapadon Other Names | PF-06649751, Tavapadon |
| Type | |
| Formula | C19H16F3N3O3 |
| Weight | Average: 391.35 Monoisotopic: 391.114375876 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
